Loading...
Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer
Tamoxifen has been considered for several decades as the standard upfront hormonal therapy for patients with endocrine-sensitive early breast cancer. The efficacy and favorable toxicity profiles of third-generation aromatase inhibitors (AIs), anastrozole, letrozole and exemestane, in advanced diseas...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer-Verlag
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3420988/ https://ncbi.nlm.nih.gov/pubmed/22930614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13193-010-0007-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|